Legal Representation
Attorney
David Ewen
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 25, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 24, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Apr 24, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Apr 24, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 20, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 18, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 18, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 18, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 25, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 28, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 28, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 8, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 20, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 19, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 19, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 19, 2023 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 19, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 17, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 4, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 2, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Medical and scientific research in the field of oncology and cancer treatment; Pharmaceutical research and development; Research and development in the field of oncology and cancer treatment
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"